Skip to content
★ Sign in to follow
JW
Total declarations
8
Company
1
▲ Purchases (1 ops.)
€42k
▼ Sales (0 ops.)
—

Latest filing published 11 May 2020 for Avanos Medical, INC., €467k.

Filing timeline

BuySale
John W. Wesley

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

John W. Wesley: trading record in brief

John W. Wesley discloses dealings in Avanos Medical, Inc. to SEC (Form 4). In total, 8 filings cover trades dated from 7 November 2014 to 7 May 2020.

No open-market sale appears; the market trades are 1 purchase worth €42k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 7 share grants.

The record was last updated on 11 May 2020 with a share grant (€467k) in Avanos Medical, Inc. The last insider purchase was made public on 20 November 2018, 2,911 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to John W. Wesley

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations8 total
  • ◆
    SVP, General CounselExecutivesAvanos Medical, Inc.
    506,239 USD19SEC
    16,506 shares@ US$30.67100.0% of flowCommon StockSEC:0001606498-20-000035:0
  • ◆
    SVP, General CounselExecutivesAvanos Medical, Inc.
    429,334 USD17SEC
    8,965 shares@ US$47.8937.5% of flowCommon StockSEC:0001606498-19-000036:0
  • ◆
    SVP, General CounselExecutivesAvanos Medical, Inc.
    135,912 USD14SEC
    2,838 shares@ US$47.8911.9% of flowCommon StockSEC:0001606498-19-000020:0
  • ▲
    SVP, General CounselExecutivesAvanos Medical, Inc.
    47,480 USD11SEC
    1,000 shares@ US$47.484.0% of flowCommon StockSEC:0001606498-18-000074:0
    Canonical exit: 17 Feb 2019 (T+90)
  • ◆
    SVP, General CounselExecutivesAvanos Medical, Inc.
    33,202 USD11SEC
    727 shares@ US$45.672.6% of flowCommon StockSEC:0001606498-17-000063:0
  • ◆
    SVP, General CounselExecutivesAvanos Medical, Inc.
    77,025 USD12SEC
    1,950 shares@ US$39.506.4% of flowCommon StockSEC:0001606498-17-000027:0
  • ◆
    See RemarksExecutivesAvanos Medical, Inc.
    0SEC
    2,178 shares0Common Stock, $0.01 par valueSEC:0001209191-14-068329:0
  • ◆
    See RemarksExecutivesAvanos Medical, Inc.
    0SEC
    5,846 shares0Common Stock, $0.01 par valueSEC:0001209191-14-068329:1

8 of 8 declarations